GRITSTONE BIO, INC.
5959 Horton Street, Suite 300
Emeryville, California 94608
December 27, 2023
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
| Attention: | Jessica Dickerson | |
| Re: | Gritstone bio, Inc. Registration Statement on Form S-3 (File No. 333- 276242) filed December 22, 2023 |
Requested Date: December 29, 2023
Requested Time: 4:00 PM Eastern Time
Ladies and Gentlemen:
Gritstone bio, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the above-captioned Registration Statement on Form S-3 effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission.
The Registrant hereby authorizes Robert A. Freedman, an attorney with the Registrant’s outside legal counsel, Fenwick & West LLP, to orally modify or withdraw this request for acceleration.
The Registrant requests that it be notified of such effectiveness by a telephone call to Mr. Freedman at (206) 389-4524.
* * *
| Sincerely, | ||
| GRITSTONE BIO, INC. | ||
| By: | /s/ Vassiliki Economides | |
| Vassiliki Economides | ||
| Chief Financial Officer | ||
| Cc | Andrew Allen, M.D., Ph.D., President and Chief Executive Officer |
Gritstone bio, Inc.
Effie Toshav, Esq.
Robert A. Freedman, Esq.
Ryan Mitteness, Esq.
Chelsea Anderson, Esq.
Fenwick & West LLP
[Signature Page to Company Acceleration Request Letter]